Evaluation of microballoon compression and microvascular decompression in the treatment of trigeminal neuralgia

doi:10.19854/j.cnki.1008-2425.2024.03.0004

Abstract

Abstract: Objective To compare the effects of microballoon compression and microvascular decompression guided by digital subtraction angiography(digitalsubtractionangiography,DSA) in the treatment of trigeminal neuralgia.Methods One hundred patients with trigeminal neuralgia treated in our hospital from January 2019 to January 2022 were randomly divided into study group(n=50) and control group(n=50).The former was treated with DSA-guided microballoon compression and the latter was treated with microvascular decompression.The pain relief rates,serum levels of interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),C-reactive protein(CRP),serum prostaglandin E2(PGE2),plasma substance P(SP) and serum calcitonin gene-related peptide(calcitoningenerelatedpeptide,CGRP) were compared between the two groups before and after operation.The concentration of peroxisome proliferator-activated receptor gamma coactivator 1-α(PGC-1 α) and serum 5-hydroxytryptamine(5-hydroxytryptamine),the incidence of complications and the recurrence rate after 6 months follow-up.Results The pain relief rate at 24 hours after operation in the study group was higher than that in the reference group(P＜0.05).24h after operation,the serum IL-6,TNF-α,CRP concentrations,serum PGE2,plasma SP concentrations,and serum CGRP concentrations in the study group were lower than those in the reference group(P＜0.05).24h after operation,the PGC-1α concentration and serum 5-HT concentration in the study group were higher than those in the reference group(P＜0.05).The complication rate and recurrence rate of the study group were similar to those of the reference group(P>0.05).Conclusion The DSA-guided microballoon compression in the treatment of trigeminal neuralgia can effectively reduce pain and is relatively less invasive.

Key words: DSA guidance, Microballoon compression, Microvascular decompression, Trigeminal neuralgia, Complications

摘要： 目的比较数字减影血管造影机(digital subtraction angiography,DSA)引导下微球囊压迫术和微血管减压术治疗三叉神经痛患者的效果。方法观察对象为100例2019年1月至2022年1月在我院进行治疗的三叉神经痛患者,引入随机数字表法将其分为研究组(50例)与参照组(50例),前者应用DSA引导下微球囊压迫术治疗,后者应用微血管减压术治疗。比较两组疼痛缓解率,手术前后血清白细胞介素-6 (IL-6)、肿瘤坏死因子-α(TNF-α)、C-反应蛋白(CRP)浓度,血清前列素E2(PGE2)浓度、血浆P物质(SP)浓度、血清降钙素基因相关肽(calcitonin gene related peptide,CGRP),过氧化物酶体增殖物激活受体γ辅激活物1-α(PGC-1α)浓度、血清5-羟色胺(5-hydroxytryptamine,5-HT)浓度、并发症发生率、随访6个月复发率。结果研究组术后24 h的疼痛缓解率,高于参照组(P＜0.05)。术后24 h,研究组的血清IL-6、TNF-α、CRP浓度,血清PGE2、血浆SP浓度,血清CGRP浓度,均低于参照组(P＜0.05)。术后24h,研究组的PGC-1α浓度、血清5-HT浓度,均高于参照组(P＜0.05)。研究组的并发症发生率、随访6个月复发率和参照组相比无差异(P＞0.05)。结论 DSA引导下微球囊压迫术治疗三叉神经痛能有效减轻疼痛,且临床操作中相对更微创。

关键词: DSA引导, 微球囊压迫术, 微血管减压术, 三叉神经痛, 并发症

CLC Number:

R745.1⁺1

Zhao Peng, Xiong Dengxi, Zha Zhengjiang, Zhou Heping, Chen Ming, Zhang Longhui. Evaluation of microballoon compression and microvascular decompression in the treatment of trigeminal neuralgia[J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2024, 37(3): 146-151.

赵, 鹏, 熊登喜, 查正江, 周和平, 陈敏, 张隆辉. 微球囊压迫术和微血管减压术对三叉神经痛治疗效果评价[J]. 立体定向和功能性神经外科杂志, 2024, 37(3): 146-151.

References

[1] 王晨晖,赵睿,冉德伟,等.三叉神经痛诊疗新进展[J].临床神经病学杂志,2019,32(5):390~393.
[2] 卢慧鹏,刘展,王艮卫,等.原发性三叉神经痛患者的血流动力异常[J].中华神经科杂志,2022,55(6):619~625.
[3] 侯锐,翟新利,方剑乔,等.原发性三叉神经痛中西医非手术诊疗方法的专家共识[J].实用口腔医学杂志,2022,38(2):149~161.
[4] 张业森,尚毓淳,姜之全,等.经皮球囊压迫术与微血管减压术治疗三叉神经痛的临床疗效比较[J].实用临床医药杂志,2022,26(2):34~37.
[5] 徐秀理,卢虎生,胡宗涛,等.国内伽玛刀与手术治疗三叉神经痛疗效的Meta分析[J].安徽医药,2017,21(11):2042~2045.
[6] 殷世武,李茂全.微创介入治疗三叉神经痛临床操作指南(第1版)[J].中国介入影像与治疗学,2020,17(7):385~388.
[7] 冉琴,尹静,赖茜,等.微血管减压术与经皮穿刺球囊/微球囊压迫术治疗原发性三叉神经痛的疗效观察[J].实用医院临床杂志,2021,18(6):188~190.
[8] Gubian A,Rosahl S K .Meta-analysis on safety and efficacy of microsurgical and radiosurgical treatment of trigeminal neuralgia[J].World Neurosurg,2017,103:757~767.
[9] Dumot C,Brinzeu A,Berthiller J,et al.Trigeminal neuralgia due to venous neurovascular conflicts:outcome after microvascular decompression in a series of 55 consecutive patients[J].Acta Neurochirurgica,2017,159(2):237~249.
[10] 向臻婷,郑晓辉.药物局部注射治疗原发性三叉神经痛的研究进展[J].国际口腔医学杂志,2016,43(1):38~42.
[11] 郭盼,周游,郐国虎.微血管减压术治疗三叉神经痛的研究进展[J].局解手术学杂志,2021,30(7):643~646.
[12] 牛纪杰,孟祥富,聂秀涛,等.原发性三叉神经痛微血管减压术后复发的相关因素分析[J].中国微侵袭神经外科杂志,2021,26(1):20~23.
[13] 王可心,乔婧,张杰,等.DSA引导下微球囊压迫技术精准治疗三叉神经痛[J].口腔医学,2020,40(8):711~714.
[14] 王勇,菅光旭,李月喜.微血管减压术与球囊压迫术治疗三叉神经痛的疗效对比[J].中国实用神经疾病杂志,2020,23(16):1434~1438.
[15] 孙承龙,朱强,杜权,等.球囊压迫术治疗三叉神经痛时标准梨形球囊与非梨形球囊的疗效比较[J].浙江医学,2022,44(3):246~249.
[16] 刘彪,郭盼,王鹏,等.微血管减压术与微球囊压迫术治疗三叉神经痛疗效的Meta分析[J].中国微侵袭神经外科杂志,2021,26(5):205~209.
[17] 胡焓,冯丹,田佳玉,等.卡马西平联合脉冲射频治疗三叉神经痛患者的疗效及对患者氧化应激、炎症因子、微量元素和免疫功能的影响[J].广西医学,2021,43(19):2300~2305.
[18] 曾强,吴珍霞,张勇,等.活血逐瘀解挛汤结合扳机点注射A型肉毒杆菌毒素对三叉神经痛患者TNF-α、IL-6水平的影响[J].广州中医药大学学报,2020,6(8):1421~1425.
[19] 庞伟,周琛,陈艳,等.A型肉毒毒素对面部三叉神经痛大鼠疼痛的改善作用及对炎性介质IL-6、TNF-α表达的影响[J].新医学,2021,7(10):752~758.
[20] 余前华,邱卫东,马君武,等.星状神经节阻滞对三叉神经痛脑微血管减压术患者炎性反应的影响[J].卒中与神经疾病,2019,26(3):317~319,323.
[21] 曹腾腾,叶蕾,郑海霞.扳机点注射A型肉毒杆菌毒素联合活血通络胶囊治疗原发性三叉神经痛疗效及对血浆CGRP、SP、IL-6、IL-1β水平的影响[J].现代中西医结合杂志,2018,27(30):3328~3331.
[22] 梁志白,赵枫.脂联素抑制人髓核细胞分泌疼痛介质PGE2的初步机制研究[J].中国现代医学杂志,2017,27(21):37~42.
[23] 南忠庆,张明晓,刘建龙,等.背根神经节脉冲射频刺激联合普瑞巴林治疗对三叉神经痛的疗效及患者血清CGRP、5-HT水平的影响[J].重庆医科大学学报,2020,6(8):1184~1187.
[24] 郜丽琴,杜玉敏,郗露露,等.降钙素基因相关肽和P物质在原发性三叉神经痛发作过程中的作用[J].中国疼痛医学杂志,2019,25(10):744~748.
[25] 王爱丽,王雪,朱太卿.通窍活血汤辅助针刺治疗三叉神经痛疗效及对PGC-1α、抗氧化指标变化的研究[J].中华中医药学刊,2021,7(11):32~34.
[26] 李杰,王卓.微血管减压术联合加巴喷丁治疗原发性三叉神经痛的疗效及对血清β-内啡肽、5-羟色胺、超氧化物歧化酶水平的影响[J].微循环学杂志,2018,4(4):37~41.
[27] 刘俊,张卿云,盛斌,等.经皮穿刺三叉神经半月节微球囊压迫术治疗原发性三叉神经痛的临床疗效分析[J].立体定向和功能性神经外科杂志,2020,33(6):342~346.
[28] 王蕊,唐玉茹,陈付强.经皮穿刺DSA/CT引导下三叉神经节微球囊短时间、重复压迫术治疗原发性三叉神经痛患者的疗效[J].中华疼痛学杂志,2020,6(1):36~42.